Mission
Save lives by applying medical lab-grade capabilities in the field at everyday life.
Vision
Real-time, in the field monitoring of physical condition primarily cardiovascular health, identifying critical health hazards and providing alerts.
YOPI's Story
YOPI Technologies was founded in 2017 following a year-long, extensive research and feasibility trials. Hemi and his colleague, Dr. Menachem Genut, made a groundbreaking discovery by developing a new method to measure in the field real-time Oxygen Consumption (VO2) and cardiovascular health and fitness through sweat’s electrolytes analysis.
This breakthrough led YOPI Technologies to development and manufacturing these sensor and device. This innovative device incorporates a unique, patented combination of software and hardware that enables the above measurement. These measurements are then converted into accurate assessments of a user’s physiological cardiovascular condition during fitness workouts.
YOPI Technologies is redefining cardiovascular monitoring and aims to assist humanity in managing health by developing unique biosensors and devices. These innovations empower our consumers to understand and act on their personal physiology in everyday life, eliminating the need for traditional healthcare entities.
YOPI Technologies is conducted its operation from a facility in Kibbutz Nir-Am in south Israel and is going to manufacture the unique components and assemble the complete devices for shipment to its soon to be establish logistics warehouse in the USA, to distribution outlets and directly to online customers.
Ion Selective Electrode Technology
The Ion selective electrode (ISE) is a special design sensor that converts changes in the concentration of a specific ion dissolved in a solution into an electrical potential.
The YOPI Technologies team has developed and patented a unique and sophisticated method for fabricating variety of ISEs. This innovative manufacturing process forms the foundation of YOPI ‘s sweat sensor technology
FDA approval
YOPI Technologies is poised to make a significant leap forward in the fight against cardiovascular disease (CVD) by seeking FDA approval for its innovative device.
FDA approval of YOPI ‘s will pave the way for its widespread adoption, enabling it to make a profound impact on global healthcare. By providing early warning signs of CVD development, the system empowers individuals to take proactive measures, such as lifestyle modifications or seeking medical consultation, to reduce their CVD risk and enhance their overall health.
Intellectual Properties
YOPI Technologies team developed a novel technology therefore applied for Numbers of patents:
·The algorithms to convert the sensor data into accurate real-time physiological measures of cardiopulmonary function health and provide guidance to the user such as risk for PCT.
·The way of producing ISE sensors using nanomaterials with specific binding properties to the target electrolytes.
·The know-how to manufacture the disposable ISE sensor in large quantities.
The Greatest people.
Our Team
Eran Granot
Electro-Chemist
Interested to have Yopi, Let’s talk
Please fill your details and we will contact you